114 related articles for article (PubMed ID: 36939275)
1. Arginase 1/2 Inhibitor OATD-02: From Discovery to First-in-man Setup in Cancer Immunotherapy.
Borek B; Nowicka J; Gzik A; Dziegielewski M; Jedrzejczak K; Brzezinska J; Grzybowski M; Stanczak P; Pomper P; Zagozdzon A; Rejczak T; Matyszewski K; Golebiowski A; Olczak J; Lisiecki K; Tyszkiewicz M; Kania M; Piasecka S; Cabaj A; Dera P; Mulewski K; Chrzanowski J; Kusmirek D; Sobolewska E; Magdycz M; Mucha L; Masnyk M; Golab J; Nowotny M; Nowak E; Napiorkowska-Gromadzka A; Pikul S; Jazwiec R; Dzwonek K; Dobrzanski P; Meyring M; Skowronek K; Iwanowski P; Zaslona Z; Blaszczyk R
Mol Cancer Ther; 2023 Jul; 22(7):807-817. PubMed ID: 36939275
[TBL] [Abstract][Full Text] [Related]
2. OATD-02 Validates the Benefits of Pharmacological Inhibition of Arginase 1 and 2 in Cancer.
Grzybowski MM; Stańczak PS; Pomper P; Błaszczyk R; Borek B; Gzik A; Nowicka J; Jędrzejczak K; Brzezińska J; Rejczak T; Güner-Chalimoniuk NC; Kikulska A; Mlącki M; Pęczkowicz-Szyszka J; Olczak J; Gołębiowski A; Dzwonek K; Dobrzański P; Zasłona Z
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010962
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment.
Steggerda SM; Bennett MK; Chen J; Emberley E; Huang T; Janes JR; Li W; MacKinnon AL; Makkouk A; Marguier G; Murray PJ; Neou S; Pan A; Parlati F; Rodriguez MLM; Van de Velde LA; Wang T; Works M; Zhang J; Zhang W; Gross MI
J Immunother Cancer; 2017 Dec; 5(1):101. PubMed ID: 29254508
[TBL] [Abstract][Full Text] [Related]
4. Myeloid Cell-Derived Arginase in Cancer Immune Response.
Grzywa TM; Sosnowska A; Matryba P; Rydzynska Z; Jasinski M; Nowis D; Golab J
Front Immunol; 2020; 11():938. PubMed ID: 32499785
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial arginase-2 is a cell‑autonomous regulator of CD8+ T cell function and antitumor efficacy.
Martí i Líndez AA; Dunand-Sauthier I; Conti M; Gobet F; Núñez N; Hannich JT; Riezman H; Geiger R; Piersigilli A; Hahn K; Lemeille S; Becher B; De Smedt T; Hugues S; Reith W
JCI Insight; 2019 Nov; 4(24):. PubMed ID: 31751318
[TBL] [Abstract][Full Text] [Related]
6. Androgen-regulated expression of arginase 1, arginase 2 and interleukin-8 in human prostate cancer.
Gannon PO; Godin-Ethier J; Hassler M; Delvoye N; Aversa M; Poisson AO; Péant B; Alam Fahmy M; Saad F; Lapointe R; Mes-Masson AM
PLoS One; 2010 Aug; 5(8):e12107. PubMed ID: 20711410
[TBL] [Abstract][Full Text] [Related]
7. Novel orally bioavailable piperidine derivatives as extracellular arginase inhibitors developed by a ring expansion.
Gzik A; Borek B; Chrzanowski J; Jedrzejczak K; Dziegielewski M; Brzezinska J; Nowicka J; Grzybowski MM; Rejczak T; Niedzialek D; Wieczorek G; Olczak J; Golebiowski A; Zaslona Z; Blaszczyk R
Eur J Med Chem; 2024 Jan; 264():116033. PubMed ID: 38096651
[TBL] [Abstract][Full Text] [Related]
8. The arginase inhibitor Nω-hydroxy-nor-arginine (nor-NOHA) induces apoptosis in leukemic cells specifically under hypoxic conditions but CRISPR/Cas9 excludes arginase 2 (ARG2) as the functional target.
Ng KP; Manjeri A; Lee LM; Chan ZE; Tan CY; Tan QD; Majeed A; Lee KL; Chuah C; Suda T; Ong ST
PLoS One; 2018; 13(10):e0205254. PubMed ID: 30307989
[TBL] [Abstract][Full Text] [Related]
9. A Novel Oral Arginase 1/2 Inhibitor Enhances the Antitumor Effect of PD-1 Inhibition in Murine Experimental Gliomas by Altering the Immunosuppressive Environment.
Pilanc P; Wojnicki K; Roura AJ; Cyranowski S; Ellert-Miklaszewska A; Ochocka N; Gielniewski B; Grzybowski MM; Błaszczyk R; Stańczak PS; Dobrzański P; Kaminska B
Front Oncol; 2021; 11():703465. PubMed ID: 34504786
[TBL] [Abstract][Full Text] [Related]
10. Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade.
Aaboe Jørgensen M; Ugel S; Linder Hübbe M; Carretta M; Perez-Penco M; Weis-Banke SE; Martinenaite E; Kopp K; Chapellier M; Adamo A; De Sanctis F; Frusteri C; Iezzi M; Zocca MB; Hargbøll Madsen D; Wakatsuki Pedersen A; Bronte V; Andersen MH
Cancer Immunol Res; 2021 Nov; 9(11):1316-1326. PubMed ID: 34518197
[TBL] [Abstract][Full Text] [Related]
11. An injectable hydrogel using an immunomodulating gelator for amplified tumor immunotherapy by blocking the arginase pathway.
Ren X; Wang N; Zhou Y; Song A; Jin G; Li Z; Luan Y
Acta Biomater; 2021 Apr; 124():179-190. PubMed ID: 33524560
[TBL] [Abstract][Full Text] [Related]
12. Endogenous arginase 2 as a potential biomarker for PEGylated arginase 1 treatment in xenograft models of squamous cell lung carcinoma.
Lam SK; Yan S; Xu S; U KP; Cheng PN; Ho JC
Oncogenesis; 2019 Feb; 8(3):18. PubMed ID: 30808864
[TBL] [Abstract][Full Text] [Related]
13. Virtual Screening for FDA-Approved Drugs That Selectively Inhibit Arginase Type 1 and 2.
Detroja TS; Samson AO
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014374
[TBL] [Abstract][Full Text] [Related]
14. The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines.
Weis-Banke SE; Hübbe ML; Holmström MO; Jørgensen MA; Bendtsen SK; Martinenaite E; Carretta M; Svane IM; Ødum N; Pedersen AW; Met Ö; Madsen DH; Andersen MH
Oncoimmunology; 2020 Jun; 9(1):1771142. PubMed ID: 32923127
[TBL] [Abstract][Full Text] [Related]
15. ARG2 impairs endothelial autophagy through regulation of MTOR and PRKAA/AMPK signaling in advanced atherosclerosis.
Xiong Y; Yepuri G; Forbiteh M; Yu Y; Montani JP; Yang Z; Ming XF
Autophagy; 2014; 10(12):2223-38. PubMed ID: 25484082
[TBL] [Abstract][Full Text] [Related]
16. Arginase: An emerging and promising therapeutic target for cancer treatment.
Niu F; Yu Y; Li Z; Ren Y; Li Z; Ye Q; Liu P; Ji C; Qian L; Xiong Y
Biomed Pharmacother; 2022 May; 149():112840. PubMed ID: 35316752
[TBL] [Abstract][Full Text] [Related]
17. Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells.
Weis-Banke SE; Lisle TL; Perez-Penco M; Schina A; Hübbe ML; Siersbæk M; Holmström MO; Jørgensen MA; Marie Svane I; Met Ö; Ødum N; Madsen DH; Donia M; Grøntved L; Andersen MH
J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36316062
[TBL] [Abstract][Full Text] [Related]
18. Single Nucleotide Polymorphisms in the Arginase 1 and 2 Genes Are Differentially Associated with Circulating l-Arginine Concentration in Unsupplemented and l-Arginine-Supplemented Adults.
Hannemann J; Rendant-Gantzberg L; Zummack J; Hillig J; Eilermann I; Böger R
J Nutr; 2021 Apr; 151(4):763-771. PubMed ID: 33232463
[TBL] [Abstract][Full Text] [Related]
19. Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma.
North ML; Khanna N; Marsden PA; Grasemann H; Scott JA
Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L911-20. PubMed ID: 19286931
[TBL] [Abstract][Full Text] [Related]
20. Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity.
Ramji K; Grzywa TM; Sosnowska A; Paterek A; Okninska M; Pilch Z; Barankiewicz J; Garbicz F; Borg K; Bany-Laszewicz U; Zerrouqi A; Pyrzynska B; Rodziewicz-Lurzynska A; Papiernik D; Sklepkiewicz P; Kedzierska H; Staruch A; Sadowski R; Ciepiela O; Lech-Maranda E; Juszczynski P; Mackiewicz U; Maczewski M; Nowis D; Golab J
Sci Rep; 2022 Nov; 12(1):19660. PubMed ID: 36385153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
